YU223884A - Process for obtaining porous form medicine with polycaprolacton matrix - Google Patents

Process for obtaining porous form medicine with polycaprolacton matrix

Info

Publication number
YU223884A
YU223884A YU02238/84A YU223884A YU223884A YU 223884 A YU223884 A YU 223884A YU 02238/84 A YU02238/84 A YU 02238/84A YU 223884 A YU223884 A YU 223884A YU 223884 A YU223884 A YU 223884A
Authority
YU
Yugoslavia
Prior art keywords
matrix
polycaprolacton
porous form
form medicine
obtaining porous
Prior art date
Application number
YU02238/84A
Other languages
English (en)
Inventor
H Grouiller
F Christ
Original Assignee
Lhd Lab Hygiene Dietetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lhd Lab Hygiene Dietetique filed Critical Lhd Lab Hygiene Dietetique
Publication of YU223884A publication Critical patent/YU223884A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Materials For Medical Uses (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
YU02238/84A 1984-01-02 1984-12-28 Process for obtaining porous form medicine with polycaprolacton matrix YU223884A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8400015A FR2557459B1 (fr) 1984-01-02 1984-01-02 Matrice inerte a base de polycaprolactone pour administration orale d'un medicament, et procede de preparation de la forme galenique comprenant cette matrice

Publications (1)

Publication Number Publication Date
YU223884A true YU223884A (en) 1987-10-31

Family

ID=9299789

Family Applications (1)

Application Number Title Priority Date Filing Date
YU02238/84A YU223884A (en) 1984-01-02 1984-12-28 Process for obtaining porous form medicine with polycaprolacton matrix

Country Status (23)

Country Link
US (1) US4629624A (hu)
EP (1) EP0147335B1 (hu)
JP (1) JPS60185729A (hu)
KR (1) KR850005271A (hu)
AT (1) ATE33553T1 (hu)
AU (1) AU574024B2 (hu)
CA (1) CA1238856A (hu)
CS (1) CS247190B2 (hu)
DD (1) DD235829A5 (hu)
DE (1) DE3470459D1 (hu)
DK (1) DK616084A (hu)
ES (1) ES8605682A1 (hu)
FI (1) FI79942C (hu)
FR (1) FR2557459B1 (hu)
GR (1) GR82607B (hu)
HU (1) HU193731B (hu)
IL (1) IL73957A (hu)
NO (1) NO160412C (hu)
OA (1) OA08018A (hu)
PH (1) PH22167A (hu)
PT (1) PT79786B (hu)
YU (1) YU223884A (hu)
ZA (1) ZA857B (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU86077A1 (fr) * 1985-09-18 1987-04-02 Pharlyse Sa Nouvelles formes galeniques du verapamil,leur fabrication et medicaments contenant ces nouvelles formes galeniques
DE3701625A1 (de) * 1987-01-21 1988-08-04 Boehringer Ingelheim Kg Perorale arzneimittelzubereitung mit verzoegerter wirkstofffreigabe
SE8701479L (sv) * 1987-04-09 1988-10-10 Carbomatrix Ab Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
GB8805286D0 (en) * 1988-03-05 1988-04-07 Schering Agrochemicals Ltd Trypanocides
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
FR2791569B1 (fr) * 1999-03-31 2003-05-09 Pf Medicament Composition ou structure microporeuse expansee isotrope a dissolution rapide a usage pharmaceutique, veterinaire, dietetique, alimentaire ou cosmetique et son procede d'obtention
US6531158B1 (en) 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
KR20060085682A (ko) * 2003-10-10 2006-07-27 라이프사이클 파마 에이/에스 피브레이트 및 스타틴을 함유하는 고형 제제
EP1680091B1 (en) * 2003-10-10 2017-05-31 Veloxis Pharmaceuticals A/S A solid dosage form comprising a fibrate
US9173847B2 (en) * 2003-10-10 2015-11-03 Veloxis Pharmaceuticals A/S Tablet comprising a fibrate
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
FR2912751B1 (fr) * 2007-02-16 2012-07-13 Arkema France Procede de preparation de polylactones et polylactames
FR2912752B1 (fr) * 2007-02-16 2012-10-05 Arkema France Procede de preparation d'un copolymere d'au moins un monomere cyclique
WO2010032128A1 (en) * 2008-09-18 2010-03-25 Purdue Pharma L.P. Pharmaceutical dosage forms comprising poly(e-caprolactone)
AU2013203747B2 (en) * 2008-09-18 2016-01-07 Purdue Pharma L.P. Pharmaceutical dosage forms comprising poly(e-caprolactone)
TW201336529A (zh) * 2011-12-09 2013-09-16 Purdue Pharma Lp 包含聚（ε－己內酯）和聚氧化乙烯之藥物劑量型

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1490855A (fr) * 1965-08-27 1967-08-04 Shell Int Research Procédé pour la fabrication d'articles en polyesters provenant de la polymérisation des lactones
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US3929937A (en) * 1972-07-28 1975-12-30 Union Carbide Corp Biodegradable shaped articles from a material comprising a particulate addition polymer in a matrix of a thermoplastic oxyalkanoyl polymer
US4095791A (en) * 1976-08-23 1978-06-20 Fairchild Camera And Instrument Corp. Cartridge programmable video game apparatus
FR2377431A1 (fr) * 1977-01-12 1978-08-11 Inst Sint Smol Procede de preparation de materiaux polymeres a pores ouverts
FR2397840B1 (hu) * 1977-07-22 1981-03-20 Cherqui Jean
US4148871A (en) * 1977-10-11 1979-04-10 Pitt Colin G Sustained subdermal delivery ofdrugs using poly(ε-caprolactone) and its copolymers

Also Published As

Publication number Publication date
FI845088A0 (fi) 1984-12-21
ES8605682A1 (es) 1986-04-01
ATE33553T1 (de) 1988-05-15
EP0147335A2 (fr) 1985-07-03
EP0147335B1 (fr) 1988-04-20
FI79942C (fi) 1990-04-10
AU574024B2 (en) 1988-06-23
HU193731B (en) 1987-11-30
PT79786A (fr) 1985-02-01
NO160412C (no) 1989-04-19
FI845088L (fi) 1985-07-03
OA08018A (fr) 1987-01-31
AU3720984A (en) 1985-07-11
CS247190B2 (en) 1986-12-18
DK616084A (da) 1985-07-03
GR82607B (en) 1985-02-11
KR850005271A (ko) 1985-08-24
FI79942B (fi) 1989-12-29
CA1238856A (en) 1988-07-05
JPS60185729A (ja) 1985-09-21
FR2557459B1 (fr) 1986-05-30
ZA857B (en) 1985-08-28
DE3470459D1 (en) 1988-05-26
FR2557459A1 (fr) 1985-07-05
PT79786B (fr) 1986-10-28
ES539187A0 (es) 1986-04-01
IL73957A (en) 1988-02-29
NO160412B (no) 1989-01-09
US4629624A (en) 1986-12-16
PH22167A (en) 1988-06-28
IL73957A0 (en) 1985-03-31
DD235829A5 (de) 1986-05-21
EP0147335A3 (en) 1985-07-31
NO845273L (no) 1985-07-03
HUT37567A (en) 1986-01-23
DK616084D0 (da) 1984-12-20

Similar Documents

Publication Publication Date Title
YU223884A (en) Process for obtaining porous form medicine with polycaprolacton matrix
CA2021767A1 (en) Method for preparing a pharmaceutical composition in the form of microparticles
DK166088A (da) Fremgangsmaade til fremstilling af kvaternaere esteraminer og anvendelse heraf
HUT49366A (en) Process for producing 2',3'-dideoxy-2',2'-difluoronucleosides and pharmaceutical compositions comprising same
CA2001572A1 (en) Compositions for treating tobacco withdrawal symptoms
EP0232061A3 (en) High-strength steel for valve springs process for producing the steel, and valve springs made of the same
HUT39454A (en) Process for preparing derivatives of glycero-phosphocholine and glycero-phospho-ethanolamine
CA2017851A1 (en) Micronised biodegradable particles, process for preparing them and the use thereof
IL83645A0 (en) 2.3.6-substituted phenylimidazole derivatives,processes for the preparation thereof,and the use thereof as growth regulators
IE870239L (en) Recombinant interleukin-2-composition
HUT58517A (en) Process for producing pharmaceutical compositions comprising 7-oxabicyloheptane prostaglandin analog, suitable for preventing or treating migrainous headache
AU6808190A (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
MW2789A1 (en) Novel furan polyols,use thereof as polyols in the formation of polyurethanes,polyurenthanes thus obtained and process for preparing same
ZA876182B (en) 2.3-dihydrofuran derivatives,process for preparing them,and their use as an intermediate for the preparation of tetrahydrofuran derivatives
HUT53773A (en) Antidotums containing substituted 1,8-naphtiridine derivatives as aktive components and process for producing the active components
HUT50340A (en) Process for producing 2'-, 12'- or 13'-substituted 3-(8'alpha-ergolinyl)-1,1-diethylurea and pharmaceutical compositions comprising the compounds
YU53988A (en) Process for preparing cyclohexan 1,3,5-triones
AR243727A1 (es) 4-alcoxi-n-(2,3-diclorofenil)benzamidas utiles como reguladores del crecimiento de las plantas.
PL277260A1 (en) Method of obtaining novel derivatives of tetrahydropyridine
CS439388A1 (en) Method of steel production with 0,4 till 1,0 mass percentage of carbon
CS362986A1 (en) Method of manufacture of steel with carbon volume over 0,3%
IE872237L (en) 2,3-dihydrofuran derivatives, process for preparing them,¹and their use as an intermediate for the preparation of¹tetrahydrofuran derivatives
ZA874090B (en) Novel carbon fibrils,method for producing the same,and compositions containing same
ZA879632B (en) Novel furan polyols,use thereof as polyols in the formation of polyurethanes,polyurethanes thus obtained and process for preparing same
CS291987A1 (en) 5,9,13-trimethyl-4,6tetradecadien-3,13-diol,3-0-acyl-derivatives thereof and process for preparing them